Healthcare -
Biotechnology - NASDAQ - US
$ 0.214
5.52 %
$ 14 M
Market Cap
-0.14
P/E
LYRA - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative LYRA - Lyra Therapeutics, Inc.
19.1 M
LAST VALUE
15.82%
2 YEAR CAGR
40.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR